Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sparsentan (DARA-a) is a first-in-class orally active and highly potent dual endothelin A and angiotensin II receptor antagonist(Ki of 9.3 and 0.8 nM, respectively)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
2 mg | In stock | $ 78.00 | |
5 mg | In stock | $ 126.00 | |
10 mg | In stock | $ 183.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 456.00 | |
100 mg | In stock | $ 669.00 | |
500 mg | In stock | $ 1,420.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 177.00 |
Description | Sparsentan (DARA-a) is a first-in-class orally active and highly potent dual endothelin A and angiotensin II receptor antagonist(Ki of 9.3 and 0.8 nM, respectively) |
Targets&IC50 | Ang II (human):0.8 nM(ki) , Ang II (rat):0.4 nM(ki), ETA (human):9.3 nM(ki) |
Synonyms | RE-021, DARA-a |
Molecular Weight | 592.75 |
Formula | C32H40N4O5S |
CAS No. | 254740-64-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 240 mg/mL (404.89 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sparsentan 254740-64-2 Endocrinology/Hormones GPCR/G Protein RAAS Endothelin Receptor RE021 Inhibitor inhibit Angiotensin Receptor RE-021 DARA-a RE 021 inhibitor